Selective pulmonary and systemic vasodilator effects of amrinone in children: New therapeutic implications
- 22 May 1993
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 21 (6) , 1461-1465
- https://doi.org/10.1016/0735-1097(93)90324-t
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Acute hemodynamic effects of converting enzyme inhibition in infants with congestive heart failureThe Journal of Pediatrics, 1990
- Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantationThe Annals of Thoracic Surgery, 1989
- Acute haemodynamic effects of nifedipine in patients with ventricular septal defect.Heart, 1988
- Intravenous use of amrinone for the treatment of the failing heartThe American Journal of Cardiology, 1985
- Inotropic and vasodilator effects of amrinone on isolated human tissueCardiovascular Research, 1984
- Effects of Digoxin in Infants with a Congested Circulatory State Due to a Ventricular Septal DefectNew England Journal of Medicine, 1983
- Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.Circulation, 1982
- Hemodynamic responses to exercise in normal childrenThe American Journal of Cardiology, 1978
- Early and late results of surgical repair of truncus arteriosus.Circulation, 1977
- Hemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects.Circulation, 1976